Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Big Digital Energy, Inc.WIZP · Entity 673 | CFO and Secretary | March 09, 2021 | March 11, 2021 |
| NeuroSense Therapeutics Ltd.NRSN · Entity 7767 | Chief Financial Officer | June 16, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Big Digital Energy, Inc.
Report date March 09, 2021 · Filed March 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 1,013,433 |
Reported balance
After 2021-03-09 transaction · row 1
1 source rowRow 1 · 2021-03-09 · Purchase · Acquired 833,333 · Balance 1,013,433 |
NeuroSense Therapeutics Ltd.
Report date June 16, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,504,050 |
Reported balance
After 2026-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-16 · Purchase · Acquired 250,000 · Balance 1,504,050 F1: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 17, 2026 20:30 UTC | NeuroSense Therapeutics Ltd. NRSN · Entity 7767 | PurchaseOrdinary Shares | 250,000 | $0.80 | $200,000.00 |
DisclosureSEC source: 0001213900-26-069662 · ownership.xml · nonDerivative · entry 1 Eisenberg Or · CIK 0001721412 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,504,050 F1 · security: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. Read SEC document |
| March 26, 2026 Filed Apr 1, 2026 20:26 UTC | NeuroSense Therapeutics Ltd. NRSN · Entity 7767 | GrantOrdinary Shares | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-038545 · ownership.xml · nonDerivative · entry 1 Eisenberg Or · CIK 0001721412 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,254,050 F1 · shares: The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 22:37 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | PurchaseCommon Stock, par value $0.001 per share | 833,333 | $0.12 | $99,999.96 |
DisclosureSEC source: 0001213900-21-014909 · ownership.xml · nonDerivative · entry 1 Eisenberg Or · CIK 0001721412 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,013,433 Read SEC document |
| June 30, 2019 Filed Sep 16, 2019 21:18 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-018176 · ownership.xml · derivative · entry 2 Eisenberg Or · CIK 0001721412 · COO, CFO, Treas & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,600 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. F2 · derivative.exercise_date: On March 31, 2019, the reporting person was granted 140,000 restricted stock units, vesting quarterly over a two year period commencing on the date of grant with the first installment issued on June 30, 2019. F2 · derivative.expiration_date: On March 31, 2019, the reporting person was granted 140,000 restricted stock units, vesting quarterly over a two year period commencing on the date of grant with the first installment issued on June 30, 2019. Read SEC document |
| June 30, 2019 Filed Sep 16, 2019 21:18 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | Exercise / conversionCommon Stock | 17,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-19-018176 · ownership.xml · nonDerivative · entry 1 Eisenberg Or · CIK 0001721412 · COO, CFO, Treas & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. Read SEC document |
| March 31, 2019 Filed Apr 3, 2019 00:25 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantRestricted Stock Units (RSU) · Derivative | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005669 · ownership.xml · derivative · entry 1 Eisenberg Or · CIK 0001721412 · Acting CEO, CFO, Treas & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,100 Underlying: Common Stock · 140,000 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. F2 · derivative.exercise_date: Vest quarterly over a two year period commencing on the date of grant. F2 · derivative.expiration_date: Vest quarterly over a two year period commencing on the date of grant. Read SEC document |
| April 04, 2018 Filed May 1, 2018 15:27 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantStock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001213900-18-005270 · f4040418eisenberg_wizepharma.xml · derivative · entry 2 Eisenberg Or · CIK 0001721412 · Acting CEO, CFO, Treas & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2025-04-04 F4 · price: The Stock Option was granted as compensation for services as the CEO of the Issuer. F3 · derivative.exercise_date: The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant. Read SEC document |
| April 04, 2018 Filed May 1, 2018 15:27 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantRestricted Stock Units (RSU) | 40,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-005270 · f4040418eisenberg_wizepharma.xml · nonDerivative · entry 1 Eisenberg Or · CIK 0001721412 · Acting CEO, CFO, Treas & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,100 F1 · kind: The RSUs were fully vested upon grant. F2 · price: The RSUs were granted as compensation for services as the CEO of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.